Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ MEDTECH — Currency translation/Other

Other segment segments

Innovative Medicine
-$155M-172%

Similar metrics at other companies

Stryker logo
SYKMedSurg and Neurotechnology — Foreign exchange and other
-$19M-204%
Vontier logo
VNTMobility Technologies — Foreign currency translation and other
$4.3M+332%
Varex Imaging Corporation logo
VREXMedical — Foreign currency translation adjustments
$1.2M—
Baxter International logo
BAXMedical Products & Therapies — Currency translation
-$17M-145%
Baxter International logo
BAXHealthcare Systems & Technologies — Currency translation and other
$5.5M+257%
Medtronic logo
MDTMedical Surgical — Currency translation and other
$110M-84.8%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:GoodwillOtherIncreaseDecrease.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — currency translation/other.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's MEDTECH — currency translation/other?
Johnson & Johnson (JNJ) reported MEDTECH — currency translation/other of -$59M in Q1 2026.
How has Johnson & Johnson's MEDTECH — currency translation/other changed year-over-year?
Johnson & Johnson's MEDTECH — currency translation/other decreased by 172.0% year-over-year, from $82M to -$59M.
What is the long-term trend for Johnson & Johnson's MEDTECH — currency translation/other?
Over 2 years (2021 to 2025), Johnson & Johnson's MEDTECH — currency translation/other has grown at a 28.5% compound annual growth rate (CAGR), from -$204M to $337M.
What does MEDTECH — currency translation/other mean?
Captures the impact of foreign exchange rate fluctuations on the valuation of goodwill and other assets within the MedTech segment. It also includes minor adjustments or reclassifications that do not fit into primary acquisition or impairment categories.